US FDA’s CoGenT Pilot At Risk? Project Orbis Success May Not Save Cell/Gene Therapy Initiative

 
• By Bridget Silverman
  
Global regulation
Concurrent submission of cell and gene therapy applications is supposed to be coming under Project CoGenT. (Shutterstock)

More from Cell & Gene Therapies

More from Advanced Technologies